Consolidated Statement of Changes in Stockholders' Equity - USD ($) $ in Thousands	Total		Common Stock [Member]	Capital in Excess of Par [Member]	Treasury Stock [Member]	Retained Earnings (Accumulated Deficit) [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Parent [Member]	Noncontrolling Interest [Member]	Cumulative Effect, Period of Adoption, Adjusted Balance [Member]	Cumulative Effect, Period of Adoption, Adjusted Balance [Member] Common Stock [Member]	Cumulative Effect, Period of Adoption, Adjusted Balance [Member] Capital in Excess of Par [Member]	Cumulative Effect, Period of Adoption, Adjusted Balance [Member] Treasury Stock [Member]	Cumulative Effect, Period of Adoption, Adjusted Balance [Member] Retained Earnings (Accumulated Deficit) [Member]	Cumulative Effect, Period of Adoption, Adjusted Balance [Member] Accumulated Other Comprehensive Income (Loss) [Member]	Cumulative Effect, Period of Adoption, Adjusted Balance [Member] Parent [Member]	Cumulative Effect, Period of Adoption, Adjusted Balance [Member] Noncontrolling Interest [Member]
Balance at Dec. 31, 2021	$ 355,828		$ 281	$ 280,038	$ (24,919)	$ 30,606	$ 1,034	$ 287,040	$ 68,788
Balance, shares at Dec. 31, 2021			28,124,629		(2,951,243)
Net income	11,353					9,841		9,841	1,512
Distributions to non-controlling interest	(1,512)								(1,512)
Stock-based compensation expense	598		$ 4	594				598
Issuance of restricted stock, net, shares			383,925
Forfeiture of restricted stock, net, shares			(5,730)
Exercise of stock options, value	152			152				152
Exercise of stock options, shares			23,192
Purchase of common stock (in Shares)					(67,660)
Purchase of common stock	(617)				$ (617)			(617)
Dividends paid on common stock	(2,044)					(2,044)		(2,044)
Other comprehensive loss, net of tax	(1,717)						(1,717)	(1,717)
Ending balance at Mar. 31, 2022	362,041		$ 285	280,784	$ (25,536)	38,403	(683)	293,253	68,788
Ending balance, shares at Mar. 31, 2022			28,526,016		(3,018,903)
Balance at Dec. 31, 2021	355,828		$ 281	280,038	$ (24,919)	30,606	1,034	287,040	68,788
Balance, shares at Dec. 31, 2021			28,124,629		(2,951,243)
Net income	35,312
Other comprehensive loss, net of tax	(4,596)
Ending balance at Sep. 30, 2022	359,889		$ 285	282,681	$ (43,741)	55,438	(3,562)	291,101	68,788
Ending balance, shares at Sep. 30, 2022			28,529,993		(5,344,923)
Balance at Dec. 31, 2021	$ 355,828		$ 281	280,038	$ (24,919)	30,606	1,034	287,040	68,788
Balance, shares at Dec. 31, 2021			28,124,629		(2,951,243)
Exercise of stock options, shares	23,745
Net change in unrealized gains on investments, net of tax	$ (4,400)
Ending balance at Dec. 31, 2022	370,524		$ 287	283,663	$ (45,538)	66,673	(3,349)	301,736	68,788	$ 360,589	$ 287	$ 283,663	$ (45,538)	$ 56,738	$ (3,349)	$ 291,801	$ 68,788
Ending balance (Accounting Standards Update 2016-13 [Member]) at Dec. 31, 2022	$ (9,935)					(9,935)		(9,935)
Ending balance, shares at Dec. 31, 2022	23,061,673		28,663,827		(5,602,154)						28,663,827		(5,602,154)
Balance at Mar. 31, 2022	$ 362,041		$ 285	280,784	$ (25,536)	38,403	(683)	293,253	68,788
Balance, shares at Mar. 31, 2022			28,526,016		(3,018,903)
Net income	14,811					13,300		13,300	1,511
Distributions to non-controlling interest	(1,511)								(1,511)
Stock-based compensation expense	863			863				863
Forfeiture of restricted stock, net, shares			(587)
Issuance in connection with vesting of restricted stock units			4,944
Purchase of common stock (in Shares)					(1,272,150)
Purchase of common stock	(9,974)				$ (9,974)			(9,974)
Dividends paid on common stock	(1,971)					(1,971)		(1,971)
Other comprehensive loss, net of tax	(1,418)						(1,418)	(1,418)
Ending balance at Jun. 30, 2022	362,841		$ 285	281,647	$ (35,510)	49,732	(2,101)	294,053	68,788
Ending balance, shares at Jun. 30, 2022			28,530,373		(4,291,053)
Net income	9,148					7,636		7,636	1,512
Distributions to non-controlling interest	(1,512)								(1,512)
Stock-based compensation expense	1,034			1,034				1,034
Forfeiture of restricted stock, net, shares			(380)
Purchase of common stock (in Shares)					(1,053,870)
Purchase of common stock	(8,231)				$ (8,231)			(8,231)
Dividends paid on common stock	(1,930)					(1,930)		(1,930)
Other comprehensive loss, net of tax	(1,461)						(1,461)	(1,461)
Ending balance at Sep. 30, 2022	359,889		$ 285	282,681	$ (43,741)	55,438	(3,562)	291,101	68,788
Ending balance, shares at Sep. 30, 2022			28,529,993		(5,344,923)
Balance at Dec. 31, 2022	$ 370,524		$ 287	283,663	$ (45,538)	66,673	(3,349)	301,736	68,788	360,589	$ 287	283,663	$ (45,538)	56,738	(3,349)	291,801	68,788
Balance, shares at Dec. 31, 2022	23,061,673		28,663,827		(5,602,154)						28,663,827		(5,602,154)
Net income	$ 16,873					15,361		15,361	1,512
Distributions to non-controlling interest	(1,512)								(1,512)
Stock-based compensation expense	1,036		$ 2	1,034				1,036
Issuance of restricted stock, net, shares			304,749
Withheld restricted stock for employees' tax obligations, shares			(91,169)
Withheld restricted stock for employees' tax obligations, value	(768)			(768)				(768)
Forfeiture of restricted stock, net, shares			(9,843)
Exercise of stock options, value	$ 292			292				292
Exercise of stock options, shares	44,583	[1]	44,583
Dividends paid on common stock	$ (1,863)					(1,863)		(1,863)
Net change in unrealized gains on investments, net of tax	506						506	506
Ending balance at Mar. 31, 2023	375,153		$ 289	284,221	$ (45,538)	70,236	(2,843)	306,365	68,788
Ending balance, shares at Mar. 31, 2023			28,912,147		(5,602,154)
Balance at Dec. 31, 2022	370,524		$ 287	283,663	$ (45,538)	66,673	(3,349)	301,736	68,788	$ 360,589	$ 287	$ 283,663	$ (45,538)	$ 56,738	$ (3,349)	$ 291,801	$ 68,788
Balance (Accounting Standards Update 2016-13 [Member]) at Dec. 31, 2022	$ (9,935)					(9,935)		(9,935)
Balance, shares at Dec. 31, 2022	23,061,673		28,663,827		(5,602,154)						28,663,827		(5,602,154)
Net income	$ 45,297
Other comprehensive loss, net of tax	(1,611)
Net change in unrealized gains on investments, net of tax	(1,600)
Ending balance at Sep. 30, 2023	$ 397,262		$ 290	286,782	$ (45,538)	91,900	(4,960)	328,474	68,788
Ending balance, shares at Sep. 30, 2023	23,363,731		28,965,885		(5,602,154)
Balance at Mar. 31, 2023	$ 375,153		$ 289	284,221	$ (45,538)	70,236	(2,843)	306,365	68,788
Balance, shares at Mar. 31, 2023			28,912,147		(5,602,154)
Net income	15,682					14,170		14,170	1,512
Distributions to non-controlling interest	(1,512)								(1,512)
Stock-based compensation expense	$ 1,214			1,214				1,214
Issuance of restricted stock, net, shares			11,734
Forfeiture of restricted stock, net, shares			(204)
Issuance in connection with vesting of restricted stock units			23,211
Exercise of stock options, shares	283	[1]	283
Dividends paid on common stock	$ (1,867)					(1,867)		(1,867)
Other comprehensive loss, net of tax	(906)						(906)	(906)
Ending balance at Jun. 30, 2023	387,764		$ 289	285,435	$ (45,538)	82,539	(3,749)	318,976	68,788
Ending balance, shares at Jun. 30, 2023			28,947,171		(5,602,154)
Net income	12,742					11,230		11,230	1,512
Distributions to non-controlling interest	(1,512)								(1,512)
Stock-based compensation expense	1,232			1,232				1,232
Forfeiture of restricted stock, net, shares			(126)
Exercise of stock options, value	$ 116		$ 1	115				116
Exercise of stock options, shares	18,840	[1]	18,840
Dividends paid on common stock	$ (1,869)					(1,869)		(1,869)
Other comprehensive loss, net of tax	(1,211)						(1,211)	(1,211)
Net change in unrealized gains on investments, net of tax	(1,200)
Ending balance at Sep. 30, 2023	$ 397,262		$ 290	$ 286,782	$ (45,538)	$ 91,900	$ (4,960)	$ 328,474	$ 68,788
Ending balance, shares at Sep. 30, 2023	23,363,731		28,965,885		(5,602,154)

[1] The aggregate intrinsic value of exercised options, which represents the difference between the price of the Company’s common stock at the exercise date and the related exercise price of the underlying options, was $0.1 million for the three and nine months ended September 30, 2023 and was $0.1 million for the year ended December 31, 2022.